Acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet — RxCUI 2744315
RxNorm drug concept · Semantic clinical drug
RxCUI 2744315
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2744315
Official nameAcetaminophen 250 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 250 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet; acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats mild to moderate pain, and moderate to severe pain when used with opioid medicines. It also lowers fever. It is given through a vein in a healthcare setting.
- What is Acetaminophen Injection used for?
- It is given as an IV infusion over 15 minutes by a healthcare professional. Your dose depends on your age and weight. Your care team follows the label and your prescriber's orders.
- The most common are nausea and vomiting. Adults may also get headache or trouble sleeping. Children may have constipation or itching.
🕸️ Concept Web — How Acetaminophen 250 MG / dextromethorphan hydrobro... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet
RxCUI 2744315 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Dextromethorphan
3289IN -
Acetaminophen / dextromethorphan
214180MIN -
Dextromethorphan hydrobromide
102490PIN
-
Acetaminophen
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / dextromethorphan Effervescent Oral Tablet
2744313SCDF -
Acetaminophen / dextromethorphan hydrobromide Effervescent Oral Tablet
2744314SCDFP -
Acetaminophen / dextromethorphan Oral Product
1151184SCDG -
Acetaminophen / dextromethorphan hydrobromide Oral Product
2662804SCDGP -
Effervescent Oral Tablet
1535727DF -
Oral Product
1151131DFG
-
Acetaminophen / dextromethorphan Effervescent Oral Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 250 MG
315259SCDC -
Dextromethorphan hydrobromide 10 MG
1014455SCDC
-
Acetaminophen 250 MG
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet) / 1 (acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG Effervescent Oral Tablet) } Pack
GPCK · 2744508 -
Acetaminophen 250 MG
SCDC · 315259 -
Dextromethorphan hydrobromide 10 MG
SCDC · 1014455 -
Acetaminophen / dextromethorphan Effervescent Oral Tablet
SCDF · 2744313 -
Acetaminophen / dextromethorphan hydrobromide Effervescent Oral Tablet
SCDFP · 2744314 -
Acetaminophen / dextromethorphan Oral Product
SCDG · 1151184 -
Acetaminophen / dextromethorphan hydrobromide Oral Product
SCDGP · 2662804
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2744315 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00280-8287-24 | 1 KIT in 1 CARTON (0280-8287-24) * 2 TABLET, EFFERVESCENT... | ALKA SELTZER COLD Cold and Flu Severe Day Night Fast Dissolve | Bayer HealthCare LLC. | 2026-06-01 |
Observed labelers:
Bayer HealthCare LLC. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.